Blons H - Search Results

1

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.

Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF, Laurent-Puig P, Lepage C; PETACC-8 Study Investigators. Taieb J, et al. Among authors: blons h. Lancet Oncol. 2014 Jul;15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun 11. Lancet Oncol. 2014. PMID: 24928083 Free article. Clinical Trial.

2

Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma.

Blons H, Cabelguenne A, Carnot F, Laccourreye O, de Waziers I, Hamelin R, Brasnu D, Beaune P, Laurent-Puig P. Blons H, et al. Int J Cancer. 1999 Aug 20;84(4):410-5. doi: 10.1002/(sici)1097-0215(19990820)84:4<410::aid-ijc14>3.0.co;2-j. Int J Cancer. 1999. PMID: 10404095 Clinical Trial.

3

Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer.

Blons H, Radicella JP, Laccourreye O, Brasnu D, Beaune P, Boiteux S, Laurent-Puig P. Blons H, et al. Mol Carcinog. 1999 Dec;26(4):254-60. Mol Carcinog. 1999. PMID: 10569802

4

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

Cabelguenne A, Blons H, de Waziers I, Carnot F, Houllier AM, Soussi T, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P. Cabelguenne A, et al. Among authors: blons h. J Clin Oncol. 2000 Apr;18(7):1465-73. doi: 10.1200/JCO.2000.18.7.1465. J Clin Oncol. 2000. PMID: 10735894

5

Sequence of molecular genetic events in colorectal tumorigenesis.

Laurent-Puig P, Blons H, Cugnenc PH. Laurent-Puig P, et al. Among authors: blons h. Eur J Cancer Prev. 1999 Dec;8 Suppl 1:S39-47. Eur J Cancer Prev. 1999. PMID: 10772417 Review.

6

Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma.

Blons H, Laccourreye O, Houllier AM, Carnot F, Brasnu D, Beaune P, Zucman-Rossi J, Laurent-Puig P. Blons H, et al. Oncogene. 2002 Jul 25;21(32):5016-23. doi: 10.1038/sj.onc.1205626. Oncogene. 2002. PMID: 12118382

7

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Lecomte T, Berger A, Zinzindohoué F, Micard S, Landi B, Blons H, Beaune P, Cugnenc PH, Laurent-Puig P. Lecomte T, et al. Among authors: blons h. Int J Cancer. 2002 Aug 10;100(5):542-8. doi: 10.1002/ijc.10526. Int J Cancer. 2002. PMID: 12124803

8

TP53 and head and neck neoplasms.

Blons H, Laurent-Puig P. Blons H, et al. Hum Mutat. 2003 Mar;21(3):252-7. doi: 10.1002/humu.10171. Hum Mutat. 2003. PMID: 12619110 Review.

9

[Cellular and neoplastic otorhinolaryngologic changes, molecular markers and therapeutic potential].

Blons H, Laccourreye O, Laurent-Puig P. Blons H, et al. Ann Otolaryngol Chir Cervicofac. 2003 Jun;120(3):152-60. Ann Otolaryngol Chir Cervicofac. 2003. PMID: 12843984 Review. French.

10

Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.

Blons H, Gad S, Zinzindohoué F, Manière I, Beauregard J, Tregouet D, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P. Blons H, et al. Clin Cancer Res. 2004 Apr 15;10(8):2594-9. doi: 10.1158/1078-0432.ccr-1116-03. Clin Cancer Res. 2004. PMID: 15102660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters